Overview of randomized perioperative polychemotherapy trials in women with early-stage breast cancer

Journal of Clinical Oncology

Volumn 15, Issue 7, 1997, Pages 2526-2535

  Clahsen, Pieter C ^a   van de Velde, Cornelis J H ^a   Goldhirsch, Aron ^a   Rossbach, Josef ^a   Sertoli, Mario R ^a   Bijnens, Luc ^a   Sylvester, Richard J ^a  

^a EORTC DATA CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; PREDNISONE; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030841871     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.7.2526     Document Type: Article

References (19)

1. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet 339:1-15, 71-85, 1992
2. Fisher B, Slack N, Katrych D, et al: Ten-year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol Obstet 140:528-534, 1975
3. Kjellgren K, Nissen-Meyer R, Norin T: Perioperative adjuvant chemotherapy in breast cancer. The Scandinavian adjuvant chemotherapy study 1. Acta Oncol 28:899-901, 1989
4. Houghton J, Baum M, Nissen-Meyer R: Is there a role for perioperative adjuvant therapy in the treatment of early breast cancer? Eur J Surg Oncol 14:227-233, 1988
5. Baum M, Houghton J, Riley D: Results of the Cancer Research Campaign adjuvant trial for perioperative cyclophosphamide and long-term tamoxifen in early breast cancer reported at the tenth year of follow-up. Cancer Research Campaign Breast Cancer Trials Group. Acta Oncol 31:251-257, 1992
6. Nissen-Meyer R, Høst H. Kjellgren K: Prolonged adjuvant chemotherapy in breast cancer. The Scandinavian adjuvant chemotherapy study 2. Acta Oncol 28:903-906, 1989
7. Ludwig Breast Cancer Study Group: Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 320:491-496, 1989
8. Goldhirsch A, Castiglione M, Gelber RD: A single perioperative adjuvant chemotherapy course for node-negative breast cancer: Five year results of trial V. International Breast Cancer Study Group (formerly Ludwig Group). Monogr Natl Cancer Inst 11:89-96, 1992
9. Ludwig Breast Cancer Study Group: Combination adjuvant chemotherapy for node-positive breast cancer. Inadequacy of a single perioperative cycle. N Engl J Med 319:677-683, 1988
10. Sertoli MR, Pronzato P, Rubagotti A, et al: Perioperative polychemotherapy for primary breast cancer: A randomized study. Proc Am Soc Clin Oncol 10:48, 1991 (abstr)
11. Clahsen PC, van de Velde CJH, Julien JP, et al: Perioperative adjuvant chemotherapy in early breast cancer patients, EORTC study 10854. Breast Cancer Res Treat 27:132, 1993 (abstr)
12. Yusuf S, Peto R, Lewis J, et al: Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 27:335-371, 1985
13. Early Breast Cancer Trialists' Collaborative Group: Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. N Engl J Med 319:1681-1692, 1988
14. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
15. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
16. Early Breast Cancer Trialists' Collaborative Group: Treatment of Early Breast Cancer, vol 1: Worldwide Evidence 1985-1990. Oxford, United Kingdom, Oxford University, 1990
17. Goldhirsch A, Gelber RD, Price KN, et al: Effect of systemic adjuvant treatment on first sites of breast cancer relapse. Lancet 343:377-381, 1994
18. Clahsen PC, van de Velde CJH, Welvaart K, et al: Ten-year results of a randomized trial evaluating prolonged low-dose adjuvant chemotherapy in node-positive breast cancer. J Clin Oncol 13:33-41, 1995
19. Veronesi U: NIH consensus meeting on early breast cancer. Eur J Cancer 26:843-844, 1990